Dr Malik: a new trial with fascinating results!

Dr Malik has read an article about Statins with great interest!

Statins are good news. 1/3 reduction in cholesterol, 1/3 reduction in risk. If you can’t tolerate them, then Gibraltar and other drugs do not have the same level of evidence. This trial ( FOURIER) now suggests that even in a background of station therapy, you get 50-60% more reduction in cholesterol, and about 15% more reduction in risk, albeit with an injection every few weeks.
It involved over 27,000 patients over 2.2 years. In such a short term frame, it is impressive that any difference in hard cardiovascular outcomes was actually seen. Heart attack, stroke and revascularisation rates all when down.
Worth thinking about!
Posted on 08 May 2017
Author: Hafsa Malik
Latest News From

The World of Cardiology

Explore the blog